Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Expected to Post Q3 2023 Earnings of $0.87 Per Share

Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) – Equities researchers at Zacks Research upped their Q3 2023 earnings per share estimates for Acadia Healthcare in a note issued to investors on Monday, March 13th. Zacks Research analyst D. Chatterjee now expects that the company will post earnings per share of $0.87 for the quarter, up from their prior forecast of $0.85. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.30 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.89 EPS.

ACHC has been the subject of a number of other research reports. Royal Bank of Canada dropped their target price on Acadia Healthcare from $94.00 to $93.00 and set an “outperform” rating for the company in a research report on Monday, December 12th. StockNews.com initiated coverage on shares of Acadia Healthcare in a research note on Thursday. They issued a “hold” rating for the company. Mizuho decreased their target price on shares of Acadia Healthcare from $87.00 to $80.00 and set a “neutral” rating on the stock in a research report on Monday, March 6th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Acadia Healthcare from $82.00 to $75.00 and set a “hold” rating for the company in a research report on Monday, March 6th. Finally, Loop Capital raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the company from $90.00 to $95.00 in a research note on Monday, December 12th. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and a consensus target price of $89.67.

Acadia Healthcare Price Performance

ACHC opened at $70.23 on Thursday. The company has a current ratio of 1.30, a quick ratio of 1.30 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $6.41 billion, a P/E ratio of 22.82, a PEG ratio of 1.46 and a beta of 1.31. The stock has a 50-day moving average price of $79.81 and a 200-day moving average price of $81.39. Acadia Healthcare has a 12-month low of $63.20 and a 12-month high of $89.85.

Institutional Trading of Acadia Healthcare

A number of institutional investors have recently modified their holdings of ACHC. Voya Investment Management LLC raised its position in Acadia Healthcare by 2.2% during the 4th quarter. Voya Investment Management LLC now owns 11,720 shares of the company’s stock valued at $965,000 after purchasing an additional 256 shares during the last quarter. Teachers Retirement System of The State of Kentucky increased its stake in shares of Acadia Healthcare by 5.8% during the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 14,525 shares of the company’s stock valued at $1,196,000 after buying an additional 800 shares during the period. Truist Financial Corp raised its holdings in shares of Acadia Healthcare by 0.3% during the fourth quarter. Truist Financial Corp now owns 49,387 shares of the company’s stock valued at $4,066,000 after acquiring an additional 171 shares in the last quarter. Chartwell Investment Partners LLC purchased a new stake in Acadia Healthcare in the fourth quarter worth $1,532,000. Finally, Bridgefront Capital LLC bought a new stake in Acadia Healthcare in the fourth quarter valued at $527,000. 99.79% of the stock is currently owned by hedge funds and other institutional investors.

About Acadia Healthcare

(Get Rating)

Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services.